Related Experiment Videos
Pituitary disease mortality: is it fiction?
Eva Marie Erfurth1, Peter Siesjö, Thomas Björk-Eriksson
1Department of Endocrinology, Skånes University Hospital, 221 85, Lund, Sweden. eva_marie.erfurth@med.lu.se
Pituitary
|February 13, 2013
Summary
Patients with pituitary tumors and hypopituitarism now have improved survival rates. Advances in hormone replacement and cardiovascular care significantly reduce risks of stroke and cardiac events, leading to normal longevity.
Area of Science:
- Endocrinology
- Neurosurgery
- Cardiology
Background:
- Significant advancements in managing pituitary tumors and hypopituitarism over the past two decades.
- Historically, increased cardiovascular disease and stroke mortality were concerns for these patients.
- Recent studies indicate a decline in cardiovascular and stroke events in growth hormone (GH) deficient patients.
Purpose of the Study:
- To review current best practices in pituitary disorder management.
- To highlight the impact of comprehensive hormone replacement and cardiovascular protection on patient longevity.
- To discuss recent progress in pituitary imaging, surgical techniques, and radiotherapy.
Main Methods:
- Review of recent literature on pituitary disorders, hormone replacement therapy (including GH replacement), cardiovascular risk management, cranial radiotherapy, and pituitary surgery techniques.
- Analysis of population-based studies demonstrating outcomes in GH-deficient patients.
Main Results:
- Complete hormone replacement, particularly long-term GH replacement, combined with cardio-protective drugs, has led to a reduced risk of non-fatal stroke and cardiac events.
- The integration of advanced pituitary imaging, surgical techniques, and optimized hormone and cardiovascular therapies is expected to normalize life expectancy.
Conclusions:
- Modern management strategies for pituitary tumors and hypopituitarism can mitigate risks of cardiovascular disease and stroke.
- Patients with pituitary disorders can anticipate normal longevity with current therapeutic approaches.
- Continued progress in pituitary imaging, surgery, and medical management offers a positive outlook for patient outcomes.
Related Concept Videos
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).